Recognition of bacterial pathogens and mucosal immunity

Cellular Microbiology

Volumn 13, Issue 5, 2011, Pages 670-676

  Jones, Rheinallt M ^a   Neish, Andrew S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PATTERN RECOGNITION RECEPTOR;

BACTERIAL TRANSLOCATION; BACTERIUM IDENTIFICATION; CROHN DISEASE; EUKARYOTE; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; INTESTINE MUCOSA; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA; SHIGELLA; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS;

ANIMALS; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INFLAMMATION; INTESTINAL MUCOSA; RECEPTORS, PATTERN RECOGNITION;

BACTERIA (MICROORGANISMS); METAZOA;

EID: 79954767134     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2011.01579.x     Document Type: Review

References (38)

1. Babbin, B.A., Jesaitis, A.J., Ivanov, A.I., Kelly, D., Laukoetter, M., and Nava, P., etal. (2007) Formyl peptide receptor-1 activation enhances intestinal epithelial cell restitution through phosphatidylinositol 3-kinase-dependent activation of Rac1 and Cdc42. J Immunol 179: 8112-8121.
2. Bryant, C.E., Spring, D.R., Gangloff, M., and Gay, N.J. (2010) The molecular basis of the host response to lipopolysaccharide. Nat Rev Microbiol 8: 8-14.
3. Corfield, A.P., Myerscough, N., Longman, R., Sylvester, P., Arul, S., and Pignatelli, M. (2000) Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut 47: 589-594.
4. Cornelis, G.R. (2006) The type III secretion injectisome. Nat Rev Microbiol 4: 811-825.
5. Cossart, P., and Sansonetti, P.J. (2004) Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 304: 242-248.
6. Epple, H.J., Kreusel, K.M., Hanski, C., Schulzke, J.D., Riecken, E.O., and Fromm, M. (1997) Differential stimulation of intestinal mucin secretion by cholera toxin and carbachol. Pflugers Arch 433: 638-647.
7. Fagarasan, S., and Honjo, T. (2003) Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol 3: 63-72.
8. Fehr, D., Casanova, C., Liverman, A., Blazkova, H., Orth, K., Dobbelaere, D., etal. (2006) AopP, a type III effector protein of Aeromonas salmonicida, inhibits the NF-kappaB signalling pathway. Microbiology 152: 2809-2818.
9. Galyov, E.E., Hakansson, S., and Wolf-Watz, H. (1994) Characterization of the operon encoding the YpkA Ser/Thr protein kinase and the YopJ protein of Yersinia pseudotuberculosis. J Bacteriol 176: 4543-4548.
10. Gewirtz, A.T., Navas, T.A., Lyons, S., Godowski, P.J., and Madara, J.L. (2001) Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 167: 1882-1885.
11. Girardin, S.E., Tournebize, R., Mavris, M., Page, A.L., Li, X., Stark, G.R., etal. (2001) CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep 2: 736-742.
12. Girardin, S.E., Boneca, I.G., Carneiro, L.A., Antignac, A., Jehanno, M., Viala, J., etal. (2003) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300: 1584-1587.
13. Gutierrez, O., Pipaon, C., Inohara, N., Fontalba, A., Ogura, Y., Prosper, F., etal. (2002) Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 277: 41701-41705.
14. Ivanov, I.I., and Littman, D.R. (2011) Modulation of immune homeostasis by commensal bacteria. Curr Opin Microbiol 14: 106-114.
15. Jones, R.M., Wu, H., Wentworth, C., Luo, L., Collier-Hyams, L., and Neish, A.S. (2008) Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 3: 233-244.
16. Karin, M., and Lin, A. (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227.
17. Kim, D.W., Lenzen, G., Page, A.L., Legrain, P., Sansonetti, P.J., and Parsot, C. (2005) The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci USA 102: 14046-14051.
18. Kobayashi, K.S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nunez, G., and Flavell, R.A. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731-734.
19. McGettrick, A.F., and O'Neill, L.A. (2010) Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr Opin Immunol 22: 20-27.
20. Marshman, E., Booth, C., and Potten, C.S. (2002) The intestinal epithelial stem cell. Bioessays 24: 91-98.
21. Medzhitov, R., and Janeway, C.A., Jr (1997) Innate immunity: the virtues of a nonclonal system of recognition. Cell 91: 295-298.
22. Migeotte, I., Communi, D., and Parmentier, M. (2006) Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev 17: 501-519.
23. Monack, D.M., Mecsas, J., Bouley, D., and Falkow, S. (1998) Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J Exp Med 188: 2127-2137.
24. Mukherjee, S., Keitany, G., Li, Y., Wang, Y., Ball, H.L., Goldsmith, E.J., and Orth, K. (2006) Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312: 1211-1214.
25. Mukherjee, S., Hao, Y.H., and Orth, K. (2007) A newly discovered post-translational modification - the acetylation of serine and threonine residues. Trends Biochem Sci 32: 210-216.
26. Niess, J.H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B.A., etal. (2005) CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307: 254-258.
27. Orth, K. (2002) Function of the Yersinia effector YopJ. Curr Opin Microbiol 5: 38-43.
28. Rimoldi, M., Chieppa, M., Larghi, P., Vulcano, M., Allavena, P., and Rescigno, M. (2005) Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood 106: 2818-2826.
29. Royan, S.V., Jones, R.M., Koutsouris, A., Roxas, J.L., Falzari, K., Weflen, A.W., etal. (2010) Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-kappaB activation. Mol Microbiol 78: 1232-1245.
30. Sansonetti, P.J. (2006) The innate signaling of dangers and the dangers of innate signaling. Nat Immunol 7: 1237-1242.
31. Sansonetti, P.J., and Di Santo, J.P. (2007) Debugging how bacteria manipulate the immune response. Immunity 26: 149-161.
32. Sartor, R.B. (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594.
33. Sharma, R., Tesfay, S., Tomson, F.L., Kanteti, R.P., Viswanathan, V.K., and Hecht, G. (2006) Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 290: G685-G694.
34. Trosky, J.E., Mukherjee, S., Burdette, D.L., Roberts, M., McCarter, L., Siegel, R.M., and Orth, K. (2004) Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus. J Biol Chem 279: 51953-51957.
35. Trosky, J.E., Li, Y., Mukherjee, S., Keitany, G., Ball, H., and Orth, K. (2007) VopA inhibits ATP binding by acetylating the catalytic loop of MKKs. J Biol Chem 282: 34299-34305.
36. Viala, J., Chaput, C., Boneca, I.G., Cardona, A., Girardin, S.E., Moran, A.P., etal. (2004) Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5: 1166-1174.
37. Viboud, G.I., and Bliska, J.B. (2005) Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol 59: 69-89.
38. Wentworth, C.C., Jones, R.M., Kwon, Y.M., Nusrat, A., and Neish, A.S. (2010) Commensal-epithelial signaling mediated via formyl peptide receptors. Am J Pathol 177: 2782-2790.